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ABSTRACT The last step of peptidoglycan polymerization involves two families of unrelated transpeptidases that are the essential
targets of-lactam antibiotics. D,D-transpeptidases of the penicillin-binding protein (PBP) family are active-site serine enzymes
that use pentapeptide precursors and are the main or exclusive cross-linking enzymes in nearly all bacteria. However, pepti-
doglycan cross-linking is performedmainly by active-site cysteine L,D-transpeptidases that use tetrapeptides inMycobacterium
tuberculosis, Clostridium difficile, and -lactam-resistant mutants of Enterococcus faecium. We have investigated reprogram-
ming of the E. faecium peptidoglycan assembly pathway by a switch from pentapeptide to tetrapeptide precursors and bypass of
PBPs by L,D-transpeptidase Ldtfm. Mutational alterations of two signal transduction systems were necessary and sufficient for
activation of the L,D-transpeptidation pathway, which is essentially cryptic in wild-type strains. The first one is a classical two-
component regulatory system, DdcRS, that controls the activity of Ldtfm at the substrate level. As previously described, loss of
DdcS phosphatase activity leads to production of the D,D-carboxypeptidase DdcY and conversion of the pentapeptide into the
tetrapeptide substrate of Ldtfm. Here we show that full bypass of PBPs by Ldtfm also requires increased Ser/Thr protein phos-
phorylation resulting from impaired activity of phosphoprotein phosphatase StpA. This enzyme negatively controlled the level
of protein phosphorylation both by direct dephosphorylation of target proteins and by dephosphorylation of its cognate kinase
Stk. In combination with production of DdcY, increased protein phosphorylation by this eukaryotic-enzyme-like Ser/Thr pro-
tein kinase was sufficient for activation of the L,D-transpeptidation pathway in the absence of mutational alteration of pepti-
doglycan synthesis enzymes.
IMPORTANCE Themechanism of acquisition of high-level ampicillin resistance involving bypass of the penicillin-binding pro-
teins (PBPs) by L,D-transpeptidase Ldtfm was incompletely understood, as production of tetrapeptide precursors following tran-
scriptional activation of the ddc locus by the DdcRS two-component regulatory system was necessary but not sufficient for full
activation of the L,D-transpeptidation pathway. Here, we identified the release of a negative control of Ser/Thr protein phosphor-
ylation mediated by phosphatase StpA as the additional factor essential for ampicillin resistance. Thus, bypass of PBPs by Ldtfm
requires the modification of signal transduction regulatory systems without any gain of function by mutational alteration of
peptidoglycan biosynthetic enzymes. In contrast, previously characterized mechanisms of antibiotic resistance involve horizon-
tal gene transfer andmutational alteration of drug targets. Activation of the L,D-transpeptidation pathway reported in this study
is an unprecedented mechanism of emergence of a newmetabolic pathway since it involved the recruitment of preexisting func-
tions following modifications of regulatory circuits.
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Enterococcus faecium and Enterococcus faecalis are commensalbacteria but also important nosocomial pathogens (1). These
bacteria have an unusually high capacity for resistance to antibi-
otics since they combine several mechanisms of intrinsic resis-
tance with the acquisition of resistance determinants by horizon-
tal gene transfer (2–4). Intrinsic -lactam resistance is mediated
by species-specific low-affinity penicillin-binding proteins
(PBPs), such as PBP5, that are thought to be sufficient for pepti-
doglycan cross-linking under conditions in which the D,D-
transpeptidase catalytic domain of all other PBPs is inactivated by
-lactams (5–7). Although -lactam resistance is conveyed by a
single PBP in the enterococci, expression of resistance depends
upon additional host factors (8, 9). In E. faecalis, factors essential
for PBP5-mediated resistance to -lactams of the cephalosporin
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class have been detected by genetic analyses but their functions
remain largely unknown. These factors include the CroRS two-
component regulatory system, which is thought to regulate genes
essential for PBP5 activity, although none of the targets of CroRS-
mediated transcriptional regulation identified so far has a demon-
strated role in peptidoglycan synthesis or cephalosporin resistance
(10–13). A serine/threonine protein kinase (IreK) was identified
as essential for ceftriaxone resistance in E. faecalis (14). Subse-
quent characterization of the associated protein phosphatase,
IreP, showed that the phosphorylation of one or several IreK sub-
strates is essential for cephalosporin resistance (15). Recently, a
substrate of IreK and IreP, designated IreB, has been identified
and shown to negatively control cephalosporin resistance (16).
Additional proteins essential for ceftriaxone resistance include bi-
functional transglycosylase-transpeptidase (class A) PBPs for
elongation of glycan chains, either PonA or PBPF (17, 18), one of
the two E. faecalis MurA synthetases (UDP-N-acetylglucosamine
1-carboxyvinyl transferase) performing the first committed stem
of peptidoglycan synthesis (19), and alanine transferase of the
Fem family for synthesis of the L-Ala–L-Ala side chain of pepti-
doglycan precursors (20). Genome-wide identification of ampi-
cillin resistance determinants in E. faecium identified a different
set of proteins contributing to intrinsic -lactam resistance, in-
cluding the L,D-transpeptidase Ldtfm, the D,D-carboxypeptidase
DdcP, and the glycosyltransferase Pgt (21).
In previous studies, we have identified a PBP5-independent
-lactam resistance mechanism in E. faecium based on in vitro
selection of mutants resistant to ampicillin (a -lactam of the
penam class) (22). We started from E. faecium D344S, a derivative
of E. faecium D344R that had spontaneously lost the pbp5 gene
(22). Parental strain D344S is hypersusceptible to ampicillin be-
cause of the absence of low-affinity PBP5 (22). In five consecutive
selection steps with increasing concentrations of ampicillin, we
obtained five mutants, M1, M2, M3, M4, and M512, that gradually
acquired high-level ampicillin resistance (22, 23). In mutant
M512, 4¡3 cross-links formed by PBPs were replaced by 3¡3
cross-links generated by an ampicillin-insensitive L,D-
transpeptidase, Ldtfm (22, 24). This enzyme cleaves the L-Lys3–D-
Ala4 peptide bond of the acyl donor and links the carbonyl group
of L-Lys3 to the acyl acceptor (24). Ldtfm and PBPs were found to
be structurally unrelated and to harbor different active-site resi-
dues for nucleophilic attack of the carbonyl group of the acyl do-
nor (Cys versus Ser, respectively) (24–26). Ldts and PBPs also
differ in their spectra of inactivation by -lactams (27). PBPs are
potentially inactivated by all -lactams, including members of the
penam (ampicillin), cephalosporin (ceftriaxone), carbapenem
(imipenem), and monobactam (aztreonam) classes, depending
upon the specific -lactam and PBP under consideration (28). In
contrast, L,D-transpeptidases are efficiently inactivated by a single
class of -lactams, the carbapenems (27, 29).
The proportion of 3¡3 cross-links generated by Ldtfm is very
low in wild-type strains of E. faecium (22). Ldtfm is constitutively
produced by parental strain D344S (23, 30), but the participation
of the L,D-transpeptidase to peptidoglycan cross-linking is mar-
ginal since this enzyme requires a tetrapeptide stem in the acyl
donor substrate (24) instead of the pentapeptide stem assembled
in the cytoplasm (31). Thus, activation of the L,D-transpeptidation
pathway requires pentapeptide-to-tetrapeptide conversion (23).
The corresponding enzyme, DdcY, was identified as a metallo-
D,D-carboxypeptidase that cleaves the C-terminal residue (D-Ala5)
of a UDP-MurNAc pentapeptide to generate the precursor of the
L,D-transpeptidation pathway (30). DdcY is encoded by a cryptic
locus, ddc, that is sporadically disseminated in E. faecium strains
and encodes a two-component regulatory system (DdcRS) in ad-
dition to DdcY (30). Activation of the ddc locus in M512 results
from a mutation in the ddcS sensor kinase gene that impairs the
phosphatase activity of the enzyme and leads to constitutive ex-
pression of the locus (30). In this investigation, we identified a
second locus involved in the activation of the L,D-transpeptidation
pathway, which encodes a eukaryotic-enzyme-like serine/threo-
nine protein kinase (Stk) and its cognate phosphatase (StpA). We
show that decreased protein dephosphorylation by StpA and the
previously characterized activation of the ddc locus are both suf-
ficient and necessary for high-level -lactam resistance mediated
by L,D-transpeptidation in E. faecium.
RESULTS
Identification of mutations necessary and sufficient for high-
level ampicillin resistance.We have previously shown that acqui-
sition of high-level resistance to ampicillin by mutant M512 re-
quires activation of the ddc locus, which encodes the D,D-
carboxypeptidase DdcY, for formation of the tetrapeptide-
containing substrate of the L,D-transpeptidase (30). In mutant
M512, activation of the locus results from a T161A substitution in
the sensor kinase DdcS that impairs the phosphatase activity of the
protein (30). Here, we show that acquisition of ampicillin resis-
tance involves the mutational alteration of a second locus encod-
ing a putative serine/threonine kinase (Stk) and a phosphatase
(StpA) (Fig. 1A). The mutation was detected in mutant M1 (first
selection step) and leads to a Thr-to-Arg substitution at position
101 of StpA, which is invariant in related phosphatases (Fig. 1B).
Acquisition of the stpA mutation by strain D344S was associ-
ated with a moderate increase in the MIC of ampicillin (from 0.06
to 0.5 g/ml) (Fig. 1C). In order to evaluate the contributions of
DdcY and StpA to resistance, the ddcY gene was cloned under the
control of constitutive promoter P2 of expression vector pJEH11
and the resulting plasmid (pJEH11ddcY) was introduced into
D344S. Production of the D,D-carboxypeptidase in this host re-
sulted in a moderate level of resistance to ampicillin (MIC, 0.5g/
ml). In contrast, plasmid pJEH11ddcY conferred high-level re-
sistance on mutant M1 (MIC, 2,000 g/ml). Thus, the T101R
substitution in StpA and production of DdcY were both necessary
and sufficient for high-level ampicillin resistance.
Selection of high-level ampicillin resistance in a D,D-
carboxypeptidase-producing background. Spontaneous mu-
tants of D344S/pJEH11ddcY were obtained on agar plates con-
taining ampicillin (4 or 8 g/ml) at a frequency of ca. 5  107.
The characterization of a total of five independent mutants in each
case revealed the expression of high-level ampicillin resistance
(MIC, 2,000 g/ml) and the presence of a mutation in stpA
(mutants Ma to Me, Fig. 1B and C). The mutations led to amino
acid substitutions in four mutants and to a frameshift mutation in
the remaining mutant. Three of the four substitutions affected
invariant residues, and the remaining substitution (S192P) was lo-
cated within a highly conserved motif (Fig. 1B). The frameshift
mutation resulted from a base deletion in codon 236 located close
to the 3= end of the stpA gene (246 codons), which encodes a
conserved region of the protein. These results indicate that muta-
tions in stpA are reproducibly selected by ampicillin in a D,D-
carboxypeptidase-producing background.
Sacco et al.
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Modulation of the ampicillin resistance level by the balance
between kinase and phosphatase activities. Overproduction of
Stk in D344S following the introduction of plasmid pJEH11stk
increased the MIC of ampicillin from 0.06 to 0.5 g/ml (Fig. 1C).
Thus, the resistance phenotypes resulting from overproduction of
Stk (D344S/pJEH11stk) and impaired StpA phosphatase activity
(mutant M1) were similar. This observation implies that the level
of ampicillin resistance increases with the level of serine and thre-
onine phosphorylation. In agreement, expression of a functional
copy of stpA impaired the expression of ampicillin resistance in
mutant M512 (data not shown). Thus, the level of ampicillin re-
sistance is modulated by a balance between kinase and phospha-
tase activities.
In vitro activities of purified Stk and StpA.A soluble fragment
of the kinase Stk (residues 1 to 338) was produced in Esche-
richia coli, purified, and analyzed by Western blotting. Recombi-
nant Stk was purified as a phosphoprotein, as shown by the detec-
tion of phosphorylated proteins (Fig. 2A) or phosphothreonine
FIG 1 Roles of ddcY and stpA in ampicillin resistance. (A) Map of the E. faecium locus encoding the protein phosphatase StpA and the serine/threonine kinase
Stk. (B) Sequence alignment of protein phosphatases. Identical and conserved amino acids are highlighted in black and gray, respectively. The positions of amino
acid substitutions detected in the mutants are indicated below the alignment. In mutant Ma, a frameshift was detected in codon 236 of stpA. (C) MICs of
ampicillin for E. faecium D344S and resistant mutants.
L,D-Transpeptidation Control by Phosphatase StpA
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residues (Fig. 2B). Mass spectrometry analyses revealed several
forms of the proteins containing one to five phosphate groups (see
Fig. S1A and B in the supplemental material). StpA fully dephos-
phorylated Stk, as shown by the complete disappearance of the
phosphorylated forms of the kinase by Western blotting (Fig. 2C
and D) and mass spectrometry (see Fig. S1 in the supplemental
material). Upon incubation with ATP, purified Stk phosphory-
lated myelin basic protein (MBP) (Fig. 2A and B). The phospho-
protein bands corresponding to phospho-MBP disappeared upon
the addition of the phosphatase StpA. These results indicate that
StpA and Stk display the protein phosphatase and kinase activities
inferred from sequence similarity. These results also indicate that
kinase Stk is a substrate of StpA.
Autophosphorylation of purified Stk in vitro. Since recombi-
nant Stk was purified as a phosphoprotein fromE. coli extracts, Stk
was dephosphorylated in vitro by the addition of StpA in a 1:10
phosphatase-to-kinase ratio (see Fig. S2 in the supplemental ma-
terial). The phosphatase StpA was removed by size exclusion chro-
matography, and the absence of phosphate groups from purified
Stk was confirmed by Western blotting and mass spectrometry
analyses. Incubation of dephosphorylated Stk with ATP and
Mn2 resulted in the phosphorylation of Stk. The reaction led to a
monophosphorylation of Stk, whereas the protein recovered from
E. coli extracts contained multiple phosphate groups (compare
Fig. S1 and S2 in the supplemental material). These results indi-
cate that Stk catalyzes the phosphorylation of at least one of its
threonine residues. The difference between the phosphorylation
patterns observed in vitro and in vivo indicates that E. coli might
produce an unknown kinase responsible for Stk phosphorylation,
although this host does not produce any Stk homologue (32).
Impact of stpAmutations on the in vitro activity of the phos-
phatase. Recombinant forms of StpA detected in ampicillin-
resistant mutants M1, Ma, Mb, Mc, Md, and Me were produced in
E. coli. The truncated form of StpA (mutant Ma) and StpA con-
taining the S192P substitution (mutant Mc) were not soluble and
could not be functionally characterized. Purification of the four
remaining proteins afforded soluble enzymes with reduced phos-
phatase activity (M1, Mb, and Me) or no detectable activity (Md)
(Table 1). The amino acid substitutions detected in the former
mutants mainly led to lower kcat values with marginal impacts on
theKm of para-nitrophenylphosphate (pNPP). The values of these
catalytic constants were determined in the presence of a high con-
centration of Mn2 (2 mM). Further analysis performed with the
wild-type enzyme showed that Mn2 is essential for activity and
that this cation cannot be replaced by Mg2, Ca2, or Zn2 (data
not shown). The phosphatase activity increased with the Mn2
concentration, and a relatively high concentration of the cation
(2 mM) was required for maximal activity (see Fig. S3 in the
supplemental material). Reduction of the Mn2 concentration
from 2 mM to 50 M led to a 100-fold decrease in the catalytic
efficiency of wild-type StpA (Table 1). Reduction of the Mn2
concentration also reduced the activity of StpA from mutants Mb
and Me. Together, these results indicated that the mutations de-
tected in the stpA gene from ampicillin-resistant mutants im-
paired the phosphatase activity of the protein, as suggested by the
positions of the mutations. Of note, sufficient Mn2 is expected to
be present in vivo for metalation of StpA since brain heart infusion
(BHI) broth contains 20 M Mn2 (33) and E. faecium accumu-
lates Mn2 because of active uptake (34, 35).
StpA and Stk do not control expression of the ddc locus or
ldtfm L,D-transpeptidase gene.We have previously shown that the
ddc locus encoding DdcY (D,D-carboxypeptidase) and DdcRS
(two-component regulatory system) is cryptic in parental strain
D344S (30). Activation of the locus in mutant M512 is due to the
T161A substitution in DdcS, which impairs the phosphatase activ-
FIG 2 In vitro activities of Stk (A and B) and StpA (C and D). Phosphopro-
teins were revealed with a commercial kit (Pro-Q; Invitrogen) (A and C) or
with phosphothreonine-specific antibodies (B and D).
TABLE 1 Catalytic constants for pNPP hydrolysis by StpA from parental strain D344S and ampicillin-resistant mutants
Substitution in StpA (strain)
Catalytic constanta in presence of Mn2 at:
2 mM 50 M
Km
(mM)
kcat
(min1)
kcat/Km
(min1 mM1)
Km
(mM)
kcat
(min1)
kcat/Km
(min1 mM1)
None (D344S) 0.66 0.09 1,200 100 1,800 290 0.69 0.17 12 1 17 4.5
T101R (M1) 1.2 0.2 0.83 0.04 0.69 0.12 NDb ND ND
D136Y (Mb) 1.8 0.5 140 15 80 23 1.5 0.4 0.09 0.01 0.06 0.02
D18Y (Md) ND ND 0.003 ND ND ND
S120R (Me) 1.3 0.1 28 0.1 22 1.6 2.6 0.7 0.23 0.02 0.09 03
a Regression values standard errors were obtained by fitting experimental data to the Michaelis-Menten equation V	 kcat ES/(Km S), where V is the initial velocity and E and S
are the initial enzyme and substrate concentrations, respectively.
b ND, not determined.
Sacco et al.
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ity of the sensor kinase. Here we show that expression of the ddc
locus is not under StpA control since DdcY and DdcS were not
detected in extracts of D344S and M1, whereas the two proteins
were produced at similar high levels by M512 and M512/
pJEH11stpA (Fig. 3). Likewise, overproduction of Stk in D344S
did not lead to any increase in the levels of DdcY and DdcS pro-
duction (data not shown). Production of the L,D-transpeptidase
Ldtfm was not affected by impaired StpA and DdcS phosphatase
activities (Fig. 3) or by Stk overproduction (data not shown).
These results show that the contribution of impaired StpA phos-
phatase activity or increased Stk activity to ampicillin resistance
did not depend upon increased production of the L,D-
transpeptidase Ldtfm or activation of the ddc locus for production
of the tetrapeptide substrate of this cross-linking enzyme.
In vivo activity of StpA. Western blot analysis of E. faecium
protein extracts was performed to determine whether the in vivo
production of StpA affects the level of threonine phosphorylation.
The intensity of three protein bands detected by antiphospho-
threonine antibodies (100, 40, and 35 kDa) was increased in mu-
tant M1 (StpA T101R) in comparison to that in parental strain
D344S (StpA) (Fig. 4). As expected, the phosphoprotein patterns
were similar in M1 and M512, whereas production of StpA by
M512/pJEH11stpA led to a decrease in the intensity of the same
set of phosphoprotein bands. These results indicate that StpA neg-
atively controls the level of threonine phosphorylation in vivo.
In vitro dephosphorylation of phosphoproteins by purified
StpA. Comparison of the level of protein phosphorylation in
crude E. faecium extracts (Fig. 4) does not allow determination of
whether the negative control mediated by StpA relies on dephos-
phorylation of phosphoproteins or an indirect effect involving
negative control of the kinase activity of Stk. In order to assay
directly for the phosphoprotein phosphatase activity of StpA,
E. faecium extracts were incubated with purified StpA and ana-
lyzed by Western blot assay (Fig. 5A). The assay was performed
with extracts from D344S, M1, M512, and D344S/pJEH11stk.
The latter strain was included to maximize the phosphorylation of
putative StpA substrates because of high-level production of the
Ser/Thr kinase. Moderate overproduction of Stk by D344S/
pJEH11stk was experimentally established by the increased in-
tensity of a 100-kDa protein band detected with anti-Stk antibod-
ies (Fig. 5B) and detection of recombinant Stk with
antipolyhistidine antibodies (Fig. 5C). The 100-kDa phosphopro-
tein band (Fig. 5A) had the same electrophoretic mobility as Stk
(Fig. 5B) and recombinant Stk containing a 6His tag (Fig. 5C).
Purification of Stk from E. faecium D344S/pJEH11stk (see
Fig. S4 in the supplemental material) indicated that the 100-kDa
phosphoprotein band corresponds to Stk.
Incubation of the extracts with purified StpA resulted in a de-
crease in the intensity of the Stk 100-kDa phosphoprotein band
(Fig. 5A). This decrease resulted from dephosphorylation of
phospho-Stk by StpA, as previously shown for purified StpA and
Stk (Fig. 2). Dephosphorylation of the phosphoprotein bands at
40 and 35 kDa by StpA was not detected (Fig. 5A). Thus, modu-
lation of the phosphorylation levels of these proteins by StpA is
indirect and may involve a negative control of the kinase activity of
Stk. Upon incubation with StpA, the intensity of the 70-kDa phos-
phoprotein band decreased in all four extracts. Thus, the phos-
phoprotein band at 70 kDa contains a substrate of StpA. These
results suggest that a subset of the proteins phosphorylated by Stk
can be dephosphorylated by StpA.
DISCUSSION
The last step of peptidoglycan polymerization involves two fami-
lies of unrelated transpeptidases of DD and LD specificities that
catalyze the formation of 4¡3 and 3¡3 cross-links (36). The
relative contributions of the two enzyme types greatly vary among
bacterial species and may also vary along the cell cycle. In E. coli,
two L,D-transpeptidases catalyze the formation of a minority (ca.
5%) of the cross-links during the exponential growth phase but
the contribution of L,D-transpeptidases to peptidoglycan cross-
linking increases in the stationary phase (13%) (37, 38). In Myco-
FIG 3 Level of production of proteins encoded by the stpA-stk, ddc, and ldtfm
loci in E. faecium strains. Crude E. faecium extracts were analyzed by Western
blotting with polyclonal antibodies raised against the protein phosphatase
StpA, the serine/threonine kinase Stk, the D,D-carboxypeptidase DdcY, the
sensor kinase DdcS, and the L,D-transpeptidase Ldtfm.
FIG 4 Western blot analysis of phosphoproteins in crude E. faecium extracts.
Phosphoproteins were detected with antiphosphothreonine polyclonal anti-
bodies. Arrows indicate the positions of the main phosphoproteins (100, 70,
40, and 35 kDa), which were named according to their relative electrophoretic
mobility.
L,D-Transpeptidation Control by Phosphatase StpA
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bacterium tuberculosis (39, 40) and M. abscessus (41), L,D-
transpeptidation is the predominant mode of peptidoglycan
cross-linking in both growth phases (70 to 80%), although L,D-
transpeptidase paralogs appear to be differently regulated during
the cell cycle (42, 43). In wild-type E. faecium, the L,D-
transpeptidase Ldtfm is constitutively produced but the enzyme
makes a marginal contribution to peptidoglycan cross-linking
(3%) (23, 30). The activity of Ldtfm is controlled at the substrate
level by the production of the D,D-carboxypeptidase DdcY, which
cleaves the C-terminal D-Ala of the stem pentapeptide to form the
essential tetrapeptide donor of the L,D-transpeptidation reaction
(23, 30). In contrast to the ldtfm gene, which is present in all of the
E. faecium isolates that have been examined (24), the ddcY and
upstream ddcRS genes are present in only a minority of the isolates
belonging to this species (30). The ddc locus is cryptic, and its
activation results from the loss of the phosphatase activity of the
DdcS sensor kinase in response to selection for ampicillin resis-
tance (30). Production of DdcY is not sufficient for the complete
bypass of PBPs by Ldtfm since the production of DdcY was asso-
ciated with an only moderate (8-fold) increase in the ampicillin
MIC (Fig. 1C). In this study, we show that the full bypass of PBPs
also requires an increase in Ser/Thr protein phosphorylation re-
sulting from impaired StpA phosphatase activity. Association of a
mutation in stpA with expression of ddcY was necessary and suf-
ficient for high-level ampicillin resistance (Fig. 1C). In support of
this conclusion, we constructed strains that sequentially acquired
a mutation in stpA and a plasmid encoding DdcY in both orders
(Fig. 1C). The stpA mutations led to impaired phosphatase activ-
ity, as inferred from their nature and positions (Fig. 1B) and a
direct assay of StpA phosphatase activity (Table 1). In agreement,
homologous residues of the phosphatase Stp from Streptococcus
agalactiae were located in the enzyme-active site (44) (see Fig. S5
in the supplemental material). Amino acid substitutions in StpA
from E. faecium mutants led to 200-fold reductions in kcat for
hydrolysis of pNPP in the presence of 50 M MnCl2. The impact
of the D136Y and S120R substitutions was less (43-fold and 7-fold
reductions, respectively) at the nonphysiological Mn2 concen-
tration of 2 mM. This observation suggests that substitutions
D136Y and S120R impaired Mn2 binding. Together, these results
indicate that amino acid substitutions in StpA affected the chem-
ical step of the dephosphorylation reaction rather than substrate
recognition. Thus, decreased protein dephosphorylation was es-
sential for acquisition of ampicillin resistance.
Several assays were used to study the protein kinase and phos-
phatase activities of purified Stk and StpA. First, we showed that
Stk catalyzes its own phosphorylation on Thr residues and subse-
quently transfers the phosphate group to a model protein (MBP)
(Fig. 2; see Fig. S2 in the supplemental material). Phospho-Stk and
phospho-MBP were dephosphorylated upon the addition of StpA
(Fig. 2). This first assay established that Stk and StpA display pro-
tein kinase and phosphatase activities, respectively, as expected
from sequence similarity to previously characterized enzymes
(45). In a second assay, we compared the level of protein phos-
phorylation in crude cell extracts from E. faecium strains harbor-
ing different alleles of stpA (Fig. 4). This analysis revealed that
impaired StpA activity increased the phosphorylation of several
phosphoprotein bands (Fig. 4), including Stk (Fig. 5), indicating
that StpA negatively modulates the level of protein phosphoryla-
tion in vivo. A third assay was used to determine whether StpA
directly dephosphorylates proteins. In this assay, crude cell ex-
tracts were prepared from an E. faecium strain harboring various
alleles of stpA and from an additional Stk-overproducing strain to
maximize protein phosphorylation (Fig. 5). Incubation of the ex-
tracts resulted in the decreased phosphorylation of three phos-
phoprotein bands (100, 70, and 35 kDa). The extent of phosphor-
ylation of a 40-kDa protein was greater in mutants with impaired
phosphatase activity, but the intensity of the phosphoprotein
band did not decrease upon incubation of the extract with purified
StpA in vitro. For this protein band, modulation of the level of
phosphorylation appears to depend upon the negative control of
Stk kinase activity by StpA. Other phosphoproteins were directly
dephosphorylated by StpA. For these phosphoproteins, negative
control of the level of phosphorylation mediated by StpA may
involve both protein dephosphorylation and negative control of
the kinase Stk.
Together, our results show that the mutational alteration of
two signal transduction systems is necessary and sufficient for
reprogramming of the peptidoglycan assembly pathway by the
production of tetrapeptide-containing precursors. The first signal
transduction system is a classical two-component regulatory sys-
tem, DdcRS, that controls the production of DdcY for conversion
of pentapeptide into tetrapeptide precursors as previously de-
scribed (30). The second system, StpA-Stk, controls the level of
phosphorylation of several proteins. Several lines of evidence in-
dicate that increased protein phosphorylation resulting from the
FIG 5 Dephosphorylation of E. faecium phosphoproteins by purified StpA.
Proteins from crude cell extracts (10 g) were incubated with () or without
() purified phosphatase StpA (3 g) for 30 min at room temperature. Pro-
teins were separated by SDS-PAGE and transferred onto PVDF membranes.
Phosphoproteins were detected with antiphosphothreonine (A), anti-Stk (B),
and antipolyhistidine (C) antibodies. Arrows indicate the positions of the
main phosphoproteins (100, 70, 40, and 35 kDa).
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mutation of stpA was required for resistance although this did not
affect the level of DdcY production. First, expression of ddcY un-
der the control of a heterologous promoter in plasmid pJEH11
was sufficient for high-level ampicillin resistance (MIC,2,000 g/
ml) in mutant M1, which produced a derivative of StpA with
reduced phosphatase activity, but not in the parental strain
D344S, which harbors a wild-type copy of stpA (Fig. 1C). Thus,
production of DdcY and impaired phosphatase activity were both
required for ampicillin resistance. Second, Western blot analysis
indicated that DdcY was produced at the same level by derivatives
of D344S and M1 harboring pJEH11ddcY, indicating, as might
have been expected, that the heterologous promoter of vector
pJEH11 is functional in both hosts independently of the stpA allele
(see Fig. S6 in the supplemental material). Conversely, DdcY was
not produced by D344S and M1, indicating that the stpAmutation
present in M1 did not lead to transcriptional activation of the
chromosomal copy of ddcY. Thus, the essential role of the stpA
mutation did not depend upon DdcY production. In agreement,
derivatives of D344S/pJEH11ddcY selected on ampicillin (mu-
tants Ma to Me) harbored mutations in stpA (Fig. 1C) that im-
paired the phosphatase activity of StpA (Fig. 1B and Table 1) and
did not affect the level of DdcY production (see Fig. S6 in the
supplemental material). Third, acquisition of a mutation in stpA
by M1 and mutants Ma to Me did not result in the production of
DdcS (Fig. 3; see Fig. S6 in the supplemental material). Thus, the
chromosomal locus ddc was not regulated in response to modula-
tion of protein phosphorylation by StpA. Together, these results
establish that alterations of DdcRS and StpA-Stk are both required
for resistance and that these signal transduction systems control
the activity of distinct sets of proteins.
Production of DdcY resulting from the introduction of plas-
mid pJEH11ddcY into M1 or loss of DdcS phosphatase activity
by M512 resulted in similar resistance phenotypes. Thus, DdcY is
the only target of DdcRS-mediated regulation that is essential for
ampicillin resistance. In contrast, StpA may affect the level of
phosphorylation of multiple proteins potentially involved in re-
sistance, as shown by modulation of the level of phosphorylation
of the 100-, 70-, 40-, and 35-kDa protein bands (Fig. 4 and 5).
Furthermore, additional fainter phosphoprotein bands were de-
tected by anti-phospho-Thr antibodies upon prolonged exposure
of Western blots (data not shown) and Ser phosphorylation was
not investigated. In agreement, phosphoproteome analyses of Fir-
micutes suggest that the number of Ser/Thr phosphoproteins may
be on the order of 100 to 200 in E. faecium (46, 47). The role of
protein phosphorylation in peptidoglycan synthesis and ampicil-
lin resistance remains to be determined.
It is striking that activation of the L,D-transpeptidation path-
way in E. faecium involves modifications of representatives of the
two main signal transduction pathways of prokaryotes, the two-
component regulatory system relying on His-to-Asp phospho-
transfer (48) and the one-component eukaryotic-enzyme-like
Ser/Thr phosphorylation system (45), in the absence of modifica-
tion of cell wall biosynthesis proteins. In contrast, previously char-
acterized mechanisms of acquisition of antibiotic resistance in-
volve horizontal gene transfer, for example, van clusters for
vancomycin resistance (49), or mutational alteration of an antibi-
otic target, for example, PBP5, in E. faecium (8, 9). Acquisition of
high-level ampicillin resistance resulting from bypass of the PBPs
by Ldtfm was found here to depend upon the alteration of regula-
tory circuits without any gain of function through gene transfer or
modification biosynthetic enzymes. This is an unprecedented ex-
ample of the emergence of a new metabolic pathway through the
recruitment of functions via the modification of regulatory cir-
cuits.
MATERIALS AND METHODS
Bacterial strains, selection of mutants, and antibiotic susceptibility as-
say. All cultures were performed at 37°C in BHI agar or broth (Difco
Laboratories). Mutants M1 and M512 were derived from E. faecium
D344S by serial selection on medium containing increasing concentra-
tions of ampicillin (22, 23). Derivatives of pJEH11 were introduced into
strains of E. faecium by conjugation (17) and electroporation (18) as pre-
viously described, except that a field of 1 kV (2-mm gap) and a shunt
resistance of 1,000  were used for the latter technique. Transformants
and transconjugants were selected on gentamicin (128 g/ml). Mutants
Ma to Me were obtained by plating D344S/pJEH11ddcY on agar con-
taining ampicillin at 4 or 8 g/ml. Colonies appeared after 5 days of
incubation at a frequency of about 5 107. MICs of ampicillin (Bristol-
Myers, Paris, France) were determined by the agar dilution method after
48 h of incubation (23).
Plasmid construction.For a description of the construction of recom-
binant plasmids encoding the E. faecium D,D-carboxypeptidase DdcY, ser-
ine/threonine kinase Stk, serine/threonine phosphatase StpA, see Text S1
in the supplemental material.
Production and purification of kinase Stk and phosphatase StpA.
Recombinant Stk and StpA containing a C-terminal 6His tag were pro-
duced in E. coli BL21(DE3). Bacteria were grown in BHI broth containing
ampicillin (100 g/ml) at 37°C to an optical density at 600 nm of 0.9.
Protein production was induced with 0.5 mM IPTG (isopropyl--D-
thiogalactopyranoside) for 19 h at 16°C. Cells were disrupted by sonica-
tion in 40 ml of 50 mM Tris-HCl (pH 8.0) containing 300 mM NaCl, and
cells debris was removed by centrifugation. Proteins were purified by af-
finity chromatography on Ni2-nitrilotriacetate (Sigma). Elution was
performed with 500 mM imidazole in 50 mM Tris buffer (pH 8.0) con-
taining 300 mM NaCl. Proteins were further purified by size exclusion
chromatography on a Superdex 75 HL26/60 column (GE Healthcare)
equilibrated with 50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl. Stk
and StpA eluted as single peaks corresponding to monomers. Proteins
were stored at20°C in the same buffer supplemented with 50% glycerol.
Western blot analysis. Polyclonal anti-DdcY and anti-DdcS rabbit
antisera were previously described (30). Anti-Ldtfm, anti-Stk, and anti-
StpA antibodies were obtained by three subcutaneous injections at 2-week
intervals of 500 g of purified protein (24) into rats for Ldtfm or into
rabbits for Stk and Stp. Antiphosphothreonine rabbit antibodies were
purchased from Invitrogen. Bacteria were lysed in 100 mM Tris-HCl
(pH 7.0) with 0.18-m glass beads (6  30 s; FastPrep; QBIOgene,
Illkirch, France). Proteins were separated by SDS-PAGE, electrotrans-
ferred to a nitrocellulose membrane (Hybond, Amersham Biosciences,
Little Chalfont, United Kingdom), and incubated with antisera at dilu-
tions of 1/1,000 (Anti-DdcY), 1/200 (anti-DdcS and anti-Ldtfm), 1/2,000
(anti-Stk), 1/1,000 (anti-StpA), and 1/2,500 (antipolyhistidine from
Sigma). Antiphosphothreonine antibodies were used at dilutions of 1/250
and 1/1,000 for analyses of crude cell extracts and purified proteins, re-
spectively. Western blot assays were incubated in Tris-buffered saline
(TBS)-Tween (10 mM Tris [pH 7.5], 150 mM NaCl, 0,025% Tween 20,
2.5% nonfat dry milk) for all antibodies except for antiphosphothreonine
antibodies (20 mM Tris [pH 7.5], 137 mM NaCl, 0.1% Tween 20, 3%
bovine serum albumin). Goat anti-rabbit or anti-rat IgGs coupled to per-
oxidase (SouthernBiotech, Birmingham, AL) were used as secondary an-
tibodies, and proteins were detected by chemiluminescence (ECL kit;
Pierce, Amersham Biosciences).
Kinase and phosphatase assays. Autophosphorylation of Stk and
phosphorylation of MBP (Sigma) were tested in kinase buffer (50 mM
Tris-HCl [pH 7.5], 25 mM NaCl, 1 mM MnCl2, 1 mM MgCl2, 1 mM
dithiothreitol, 0.1 mM EDTA) in the presence or absence of ATP (2 mM)
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at room temperature. Dephosphorylation of Stk and MBP (Sigma) by
StpA was tested by adding purified StpA (4 M) to the kinase assay mix-
ture. For dephosphorylation of phosphoproteins from E. faecium crude
cell extract, purified StpA (3 g) was incubated with E. faecium crude cell
extract (10 g) in 20 l of 100 mM phosphatase buffer (pH 6.4) contain-
ing 2 mM MnCl2 for 30 min at room temperature. Reactions were
quenched with Laemmli SDS sample buffer and boiled for 5 min. Proteins
were separated by 12% SDS-PAGE and transferred to polyvinylidene di-
fluoride (PVDF) transfer membrane (Immobilon-FL; Millipore). Phos-
phorylated proteins were detected with a Pro-Q Diamond phosphopro-
tein blot stain kit (Invitrogen) according to the manufacturer’s
instructions. Blots were washed in TBS-Tween for serial detection of
phosphoproteins with the Pro-Q kit and antiphosphothreonine antibod-
ies.
Hydrolysis of pNPP (Sigma) by StpA was determined at 37°C in
50 mM Tris-HCl (pH 8.0) containing various concentrations of MnCl2.
Reactions were initiated by the addition of MnCl2, and absorbance at
405 nm ( 	 12,500 M1 cm1) was monitored with a Cary 100 Bio
spectrophotometer (Varian).
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